BPC157 as Potential Agent Rescuing from Cancer Cachexia Cancer cachexia, a debilitating clinical condition, is characterized by significant weight loss accompanied by specific losses of skeletal muscle and adipose tissue
Hsieh M-J, Liu H-T, Wang C-N, Huang H-Y, Lin Y, Ko Y-S, et al
Renowned for enhancing sleep quality, normalizing circadian rhythms, and reducing sleep disturbances, DSIP represents a beacon of hope for individuals facing chronic insomnia or other sleep-related challenges ( 1, 2, 3 )
The companies that shut down generally shared common risk factors: aggressive marketing practices, thin quality documentation, overly broad product catalogs mixing peptides with SARMs or controlled substances, and pricing that undercut the cost of legitimate synthesis
Many people seek these therapies to reduce hunger, improve portion control, and support steady weight loss when paired with nutrition, activity, and sleep habits